The Effect of Clopidogrel and Ticagrelor on Human Adipose Mesenchymal Stem Cell Osteogenic Differentiation Potential: In Vitro Comparative Study
Ticagrelor (TICA) and clopidogrel (CLP) are extensively used antiplatelet drugs that act by antagonizing the P2Y12 receptors that are found on platelets in addition to bone cells. Aim. The purpose of this study was to investigate the effect of clopidogrel and ticagrelor on stem cells osteogenic diff...
Saved in:
Main Authors: | Sally S. Mohamed, Hala F. Zaki, Shereen N. Raafat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Advances in Pharmacological and Pharmaceutical Sciences |
Online Access: | http://dx.doi.org/10.1155/2024/2990670 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An In Vitro and In Vivo Comparison of Osteogenic Differentiation of Human Mesenchymal Stromal/Stem Cells
by: Jamie Mollentze, et al.
Published: (2021-01-01) -
Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes
by: Peixun He, et al.
Published: (2021-01-01) -
In Vitro Uptake of Hydroxyapatite Nanoparticles and Their Effect on Osteogenic Differentiation of Human Mesenchymal Stem Cells
by: Xing Yang, et al.
Published: (2018-01-01) -
Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial
by: Mohammadjavad Mehdizadeh Parizi, et al.
Published: (2023-01-01) -
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
by: Bartosz Olechowski, et al.
Published: (2016-01-01)